Related Experiment Video
Updated: Jan 17, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Association between systemic inflammation response index and atrial fibrillation in chronic obstructive pulmonary
Hao Xu1, Tianye Li2, Mengya Yang1
1Zhejiang Province Engineering Research Center for Endoscope Instruments and Technology Development, Clinical Research Center, Department of Pulmonary and Critical Care Medicine, Quzhou People's Hospital, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou, China.
Background:
Systemic inflammation plays a critical role in the pathogenesis of both chronic obstructive pulmonary disease (COPD) and atrial fibrillation (AF). As an emerging biomarker reflecting systemic inflammatory status, the association between the systemic inflammation response index (SIRI) and the risk of AF in patients with COPD remains unclear. Therefore, this study aimed to investigate the association between SIRI levels and the risk of AF in patients with COPD.
Methods:
In this multicenter cross-sectional study, we enrolled 1,133 hospitalized COPD patients from May 2021 to May 2024 at the First Affiliated Hospital of Wenzhou Medical University and Quzhou People's Hospital. Patients were categorized into four groups based on SIRI quartiles. We used multivariate logistic regression, restricted cubic spline (RCS) analysis, and receiver operating characteristic (ROC) curves to evaluate the association between SIRI and AF risk. Subgroup, interaction, and sensitivity analyses were conducted to assess robustness and effect modification.
Results:
Among the study population, 225 patients (19.85%) had AF. After full adjustment, this cross-sectional analysis demonstrates that each 1-unit increase in SIRI was associated with a 4.6% higher AF risk (OR = 1.046, 95% CI: 1.018-1.075, p = 0.002). Patients in the highest SIRI quartile had a 116.2% increased risk compared to those in the lowest quartile (OR = 2.162, 95% CI: 1.325-3.527, p = 0.002). RCS analysis revealed a significant linear dose-response relationship between SIRI and AF risk. ROC analysis showed that combining SIRI with conventional risk factors improved predictive accuracy for AF (AUC = 0.818, 95% CI: 0.787-0.848, p < 0.001). A significant interaction was observed among smokers (interaction p = 0.006), and results remained robust in sensitivity analyses.
Conclusion:
Elevated SIRI levels are independently associated with an increased risk of AF in patients with COPD, especially among smokers. As a simple and readily accessible biomarker of low-grade systemic inflammation, SIRI may serve as an effective tool for assessing the risk of atrial fibrillation in patients with COPD.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
05:43Author Spotlight: Improving Lesion Contiguity in Pulmonary Vein Isolation via Proactive Esophageal Cooling
Published on: April 19, 2024
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:23Rheumatic Heart Disease I: Introduction
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...